Medicinal Products
Yasnal Q-Tab 5 mg raspadljive tablete za usta
Name |
Yasnal Q-Tab 5 mg raspadljive tablete za usta |
Marketing Authorisation Number |
HR-H-962945739 |
Active Substance |
donepezilklorid hidrat |
Composition |
svaka raspadljiva tableta za usta sadrži 5 mg donepezilklorida u obliku donepezilklorid hidrata |
Pharmaceutical Form |
raspadljiva tableta za usta |
Manufacturer |
Krka d.d., Novo mesto, Novo Mesto, Slovenija |
Marketing Authorisation Holder |
Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska |
Marketing Authorisation Date |
23.05.2017 |
MA Period of Validity |
unlimited |
Classification Number |
UP/I-530-09/16-02/454 |
Registration Number |
381-12-01/30-17-05 |
Prescription |
Medicinal product subject to medical prescription |
Type of prescription |
ponovljivi recept
|
Distribution |
Supply through pharmacies (community) |
Advertising to general public |
not allowed |
ATC Code |
N06DA02 |
Marketing status |
nije stavljeno u promet |
SmPC |
download |
PL |
download |
Packaging
Packaging description |
MA Number for Packaging |
Marketing status |
Shortage status |
10 tableta u blisteru, u kutiji |
HR-H-962945739-01 |
nije stavljeno u promet |
- |
28 tableta u blisteru, u kutiji |
HR-H-962945739-02 |
nije stavljeno u promet |
- |
30 tableta u blisteru, u kutiji |
HR-H-962945739-03 |
nije stavljeno u promet |
- |
50 tableta u blisteru, u kutiji |
HR-H-962945739-04 |
nije stavljeno u promet |
- |
56 tableta u blisteru, u kutiji |
HR-H-962945739-05 |
nije stavljeno u promet |
- |
60 tableta u blisteru, u kutiji |
HR-H-962945739-06 |
nije stavljeno u promet |
- |
84 tablete u blisteru, u kutiji |
HR-H-962945739-07 |
nije stavljeno u promet |
- |
90 tableta u blisteru, u kutiji |
HR-H-962945739-08 |
nije stavljeno u promet |
- |
98 tableta u blisteru, u kutiji |
HR-H-962945739-09 |
nije stavljeno u promet |
- |
100 tableta u blisteru, u kutiji |
HR-H-962945739-10 |
nije stavljeno u promet |
- |
Direct Healthcare Professional Communication
Name |
Date |
Download |
Pismo zdravstvenim radnicima o poremećajima srčane provodljivosti vezanima uz donepezil |
23.03.2022 |
HALMED |
Back